Versant Venture Capital IV, L.P. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Versant Venture Capital IV, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Versant Venture Capital IV, L.P.. Versant Venture Capital IV, L.P. is a 10% Owner in Ophthotech Corp. ($OPHT) and a 10% Owner in CRISPR Therapeutics AG ($CRSP).
Address: 3000 SAND HILL ROAD BUILDING FOUR, SUITE 210 MENLO PARK 94025 CA
Companies in which Versant Venture Capital IV, L.P. is an Insider
CRISPR Therapeutics AG
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Versant Venture Capital IV, L.P.: 10% Owner
Holdings: 2,238,979 shares
Current Value: $35,263,919
Latest Transaction: Apr 24 2018
$CRSP Market Capitalization: $605.88M
$CRSP Previous Close: $15.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IVERIC bio, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Versant Venture Capital IV, L.P.: 10% Owner
Holdings: 1,714,111 shares
Current Value: $7,593,512
Latest Transaction: Jun 23 2020
$OPHT Market Capitalization: $156.71M
$OPHT Previous Close: $4.43
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Versant Venture Capital IV, L.P.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2020 | OPHT | IVERIC bio, Inc. | Versant Venture Capital IV, L. ... | 10% Owner | Sell | J | 0.00 | 34,282 | 0 | 0 | 34.3 K to 0 (-100.00 %) |
| Jun 23 2020 | OPHT | IVERIC bio, Inc. | Versant Venture Capital IV, L. ... | 10% Owner | Buy | J | 0.00 | 34,282 | 0 | 34,282 | 0 to 34.3 K |
| Jun 23 2020 | OPHT | IVERIC bio, Inc. | Versant Venture Capital IV, L. ... | 10% Owner | Sell | J | 0.00 | 21,597 | 0 | 10,798 | 32.4 K to 10.8 K (-66.67 %) |
| Jun 23 2020 | OPHT | IVERIC bio, Inc. | Versant Venture Capital IV, L. ... | 10% Owner | Sell | J | 0.00 | 3,428,221 | 0 | 1,714,111 | 5.1 M to 1.7 M (-66.67 %) |
| Jan 16 2019 | OPHT | Ophthotech Corp. | Versant Venture Capital IV, L. ... | 10% Owner | Buy | J | 2.30 | 817 | 1,878 | 32,394 | 31.6 K to 32.4 K (+2.59 %) |
| Jan 16 2019 | OPHT | Ophthotech Corp. | Versant Venture Capital IV, L. ... | 10% Owner | Buy | J | 2.30 | 129,709 | 298,123 | 5,142,333 | 5 M to 5.1 M (+2.59 %) |
| Apr 24 2018 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Sell | S | 50.66 | 6,821 | 345,552 | 117,173 | 124 K to 117.2 K (-5.50 %) |
View all Versant Venture Capital IV, L.P. insider transactions.